Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panobinostat Monotherapy in Relapsed/Refractory Multiple Myeloma
NCT00445068Phase 2Terminated
- Sponsor
- Novartis
- Start
- Apr 2007
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of panobinostat in multiple myeloma (MM), sponsored by Novartis. Started Apr 2007; status: terminated.
02
Drugs
panobinostat
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00445068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00445068.